Genetic Ablation of Luteinizing Hormone Receptor Improves the Amyloid Pathology in a Mouse Model of Alzheimer Disease
Authors:
Open Access
- 1 March 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Neuropathology & Experimental Neurology
- Vol. 69 (3) , 253-261
Abstract
Amyloid-β peptide (Aβ) plays an essential pathophysiologic role in Alzheimer disease, and elevation of luteinizing hormone (LH) levels during aging haKeywords
This publication has 66 references indexed in Scilit:
- Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brainNeurobiology of Aging, 2010
- γ-Secretase Heterogeneity in the Aph1 Subunit: Relevance for Alzheimer’s DiseaseScience, 2009
- Novel Role of RanBP9 in BACE1 Processing of Amyloid Precursor Protein and Amyloid β Peptide GenerationJournal of Biological Chemistry, 2009
- Epilepsy and Cognitive Impairments in Alzheimer DiseaseArchives of Neurology, 2009
- Cognitive Changes After Menopause: Influence of EstrogenClinical Obstetrics and Gynecology, 2008
- Human chorionic gonadotropin (a luteinizing hormone homologue) decreases spatial memory and increases brain amyloid-β levels in female ratsHormones and Behavior, 2008
- A luteinizing hormone receptor intronic variant is significantly associated with decreased risk of Alzheimer's disease in males carrying an apolipoprotein E ε4 alleleBMC Medical Genetics, 2008
- Progression of Amyloid Pathology to Alzheimer's Disease Pathology in an Amyloid Precursor Protein Transgenic Mouse Model by Removal of Nitric Oxide Synthase 2Journal of Neuroscience, 2008
- Elevated Gonadotropin Levels in Patients With Alzheimer DiseaseMayo Clinic Proceedings, 2001
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991